Page last updated: 2024-10-27

fenofibrate and Deafness

fenofibrate has been researched along with Deafness in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Deafness: A general term for the complete loss of the ability to hear from both ears.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, X1
Chen, Y1
Tong, N1
Shao, Q1
Zhou, Y1
Mu, T1
Yang, X1
Zhang, Y1

Other Studies

1 other study available for fenofibrate and Deafness

ArticleYear
Maternally inherited diabetes and deafness coexists with lipoprotein lipase gene mutation-associated severe hyperlipidemia that was resistant to fenofibrate and atorvastatin, but sensitive to bezafibrate: A case report.
    Journal of diabetes investigation, 2022, Volume: 13, Issue:2

    Topics: Atorvastatin; Bezafibrate; Deafness; Diabetes Mellitus, Type 2; Female; Fenofibrate; Humans; Hyperli

2022